Simple Summary This is an important point of view that the development of breast carcinogenesis is not only related to the intrinsic characteristics of the cancer cells, but that it is also strongly dependent on surrounding microenvironmental factors. It is important to note that triple-positive breast cancer accounts for about 10-15% of all breast cancers, and research on the tumor microenvironment for this subtype is still limited. In this review, authors explored the relationship between critical cellular components and factors in the triple-positive breast cancer microenvironment and the inception, advancement, and therapeutic resistance of breast cancer to provide perspectives on the latest research on triple-positive breast cancer. The authors sufficiently described the state of the art and reported the fundamental concepts, allowing an easy comprehension of the intricate dynamics within tumor microenvironment in triple-positive breast cancer.Abstract Breast cancer (BRCA) is a highly heterogeneous systemic disease. It is ranked first globally in the incidence of new cancer cases and has emerged as the primary cause of cancer-related death among females. Among the distinct subtypes of BRCA, triple-positive breast cancer (TPBC) has been associated with increased metastasis and invasiveness, exhibiting greater resistance to endocrine therapy involving trastuzumab. It is now understood that invasion, metastasis, and treatment resistance associated with BRCA progression are not exclusively due to breast tumor cells but are from the intricate interplay between BRCA and its tumor microenvironment (TME). Accordingly, understanding the pathogenesis and evolution of the TPBC microenvironment demands a comprehensive approach. Moreover, addressing BRCA treatment necessitates a holistic consideration of the TME, bearing significant implications for identifying novel targets for anticancer interventions. This review expounds on the relationship between critical cellular components and factors in the TPBC microenvironment and the inception, advancement, and therapeutic resistance of breast cancer to provide perspectives on the latest research on TPBC.
机构:
Baylor Coll Med, Dept Surg, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX 77030 USABaylor Coll Med, Dept Surg, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX 77030 USA
Farrow, Buckminster
Albo, Daniel
论文数: 0引用数: 0
h-index: 0
机构:
Baylor Coll Med, Dept Surg, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX 77030 USABaylor Coll Med, Dept Surg, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX 77030 USA
Albo, Daniel
Berger, David H.
论文数: 0引用数: 0
h-index: 0
机构:
Baylor Coll Med, Dept Surg, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX 77030 USABaylor Coll Med, Dept Surg, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX 77030 USA
机构:
Xinjiang Med Univ, Affiliated Hosp 1, Digest & Vasc Ctr, Dept Breast Canc, Urumqi 830054, Xinjiang, Peoples R ChinaXinjiang Med Univ, Affiliated Hosp 1, Digest & Vasc Ctr, Dept Breast Canc, Urumqi 830054, Xinjiang, Peoples R China
Guo, Liying
Zhu, Qianwen
论文数: 0引用数: 0
h-index: 0
机构:
Taishan Med Univ, Affiliated Hosp, Dept Gen Surg, Tai An 271000, Shandong, Peoples R ChinaXinjiang Med Univ, Affiliated Hosp 1, Digest & Vasc Ctr, Dept Breast Canc, Urumqi 830054, Xinjiang, Peoples R China
Zhu, Qianwen
Aisimutuola, Mulati
论文数: 0引用数: 0
h-index: 0
机构:
Xinjiang Med Univ, Affiliated Hosp 1, Digest & Vasc Ctr, Dept Breast Canc, Urumqi 830054, Xinjiang, Peoples R ChinaXinjiang Med Univ, Affiliated Hosp 1, Digest & Vasc Ctr, Dept Breast Canc, Urumqi 830054, Xinjiang, Peoples R China
Aisimutuola, Mulati
Yilamu, Dilimina
论文数: 0引用数: 0
h-index: 0
机构:
Xinjiang Med Univ, Affiliated Hosp 1, Digest & Vasc Ctr, Dept Breast Canc, Urumqi 830054, Xinjiang, Peoples R ChinaXinjiang Med Univ, Affiliated Hosp 1, Digest & Vasc Ctr, Dept Breast Canc, Urumqi 830054, Xinjiang, Peoples R China
Yilamu, Dilimina
Liu, Sha
论文数: 0引用数: 0
h-index: 0
机构:
Xinjiang Med Univ, Affiliated Hosp 1, Digest & Vasc Ctr, Dept Breast Canc, Urumqi 830054, Xinjiang, Peoples R ChinaXinjiang Med Univ, Affiliated Hosp 1, Digest & Vasc Ctr, Dept Breast Canc, Urumqi 830054, Xinjiang, Peoples R China
Liu, Sha
Jakulin, Adina
论文数: 0引用数: 0
h-index: 0
机构:
Xinjiang Med Univ, Affiliated Hosp 1, Digest & Vasc Ctr, Dept Breast Canc, Urumqi 830054, Xinjiang, Peoples R ChinaXinjiang Med Univ, Affiliated Hosp 1, Digest & Vasc Ctr, Dept Breast Canc, Urumqi 830054, Xinjiang, Peoples R China
机构:
Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R ChinaChongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R China
Tang, Renxi
Zhang, Xiang
论文数: 0引用数: 0
h-index: 0
机构:
Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R ChinaChongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R China
Zhang, Xiang
Li, Hongyuan
论文数: 0引用数: 0
h-index: 0
机构:
Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R ChinaChongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R China
机构:Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200032, Peoples R China
Yu, Tianjian
Di, Genhong
论文数: 0引用数: 0
h-index: 0
机构:
Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200032, Peoples R China
Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R ChinaFudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200032, Peoples R China
机构:
Department of Breast Surgery, Fudan University Shanghai Cancer Center
Department of Oncology, Shanghai Medical College, Fudan UniversityDepartment of Breast Surgery, Fudan University Shanghai Cancer Center
Tianjian Yu
Genhong Di
论文数: 0引用数: 0
h-index: 0
机构:
Department of Breast Surgery, Fudan University Shanghai Cancer Center
Department of Oncology, Shanghai Medical College, Fudan UniversityDepartment of Breast Surgery, Fudan University Shanghai Cancer Center